Long-Term Outcomes in Patients With Progressive Forms of Relapsing MS Treated With Teriflunomide: Real-World Evidence

被引：0
|
作者：
Nelson, Flavia [1 ]
Lebrun-Frenay, Christine [2 ]
Boyko, Alexey [3 ]
Thangavelu, Karthinathan [4 ]
Mandel, Matt [4 ]
Cavalier, Steve [4 ]
Truffinet, Philippe [4 ]
Liang, Jinjun [4 ]
Berkovich, Regina [5 ]
机构：
[1] UTHealth, McGovern Med Sch, Houston, TX USA
[2] Hop Pasteur 2, Nice, France
[3] Russian State Med Univ, Yusupovs Hosp, NeuroClin, Moscow, Russia
[4] Sanofi, Cambridge, MA USA
[5] USC MS Comprehens Care Ctr & Res Grp, Los Angeles, CA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S8.004
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Long-Term Outcomes in Patients with Progressive Forms of Relapsing MS Treated with Teriflunomide: Real-World Evidence
    Berkovich, Regina
    Thangavelu, Karthinathan
    Cavalier, Steven J.
    Truffinet, Philippe
    Nelson, Flavia
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 20 - 20
  • [2] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: Patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, Flavia
    Boyko, Alexey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cavalier, Steven
    Truffinet, Philippe
    Liang, Jinjun
    Lebrun-Frenay, Christine
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 145 - 145
  • [3] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, F.
    Lebrun-Frenay, C.
    Camu, W.
    Boyko, A.
    Thangavelu, K.
    Mandel, M.
    Cavalier, S.
    Truffinet, P.
    Liang, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 940 - 941
  • [4] Long-term Efficacy of Teriflunomide in Patients Recently Diagnosed With Relapsing Forms of MS
    Oh, Jiwon
    Freedman, Mark S.
    Miller, Aaron E.
    Thangavelu, Karthinathan
    Truffine, Philippe
    Comi, Giancarlo
    [J]. NEUROLOGY, 2017, 88
  • [5] Long-term efficacy of teriflunomide in patients recently diagnosed with relapsing forms of MS
    Freedman, M.
    Comi, G.
    Miller, A.
    Wolinsky, J.
    Oh, J.
    Thangavelu, K.
    Truffinet, P.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 666 - 666
  • [6] Outcomes in Patients with Progressive MS: Analysis of Teriflunomide Long-Term Extension Data
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Camu, William
    Boyko, Alexey
    Thangavelu, Karthinathan
    Rufi, Pascal
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Lublin, Fred
    [J]. NEUROLOGY, 2016, 86
  • [7] Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
    Sormani, Maria Pia
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Rufi, Pascal
    Simonson, Catherine
    De Stefano, Nicola
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (05):
  • [8] REAL-WORLD LONG TERM OUTCOMES IN NATALIZUMAB TREATED PATIENTS
    Wynford-Thomas, Ray
    Owen, Helen
    Mulloch, Sue
    Evans, Peter
    Conway, Bernie
    Watson, Lynne
    Pearson, Owen
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [9] Comparative Effectiveness of Teriflunomide and Dimethyl Fumarate in Patients With Relapsing Forms of MS in the Real-World Teri-RADAR Study
    Zivadinov, Robert
    Burudpakdee, Chakkarin
    Dwyer, Michael G.
    Bergsland, Niels
    Chavin, Jeffrey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cohan, Stanley
    [J]. NEUROLOGY, 2018, 90
  • [10] Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study
    Zivadinov, Robert
    Kresa-Reahl, Kiren
    Weinstock-Guttman, Bianca
    Edwards, Keith
    Burudpakdee, Chakkarin
    Bergsland, Niels
    Dwyer, Michael G.
    Khatri, Bhupendra
    Thangavelu, Karthinathan
    Chavin, Jeffrey
    Mandel, Matt
    Cohan, Stanley
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (05) : 305 - 316
12345